clinical trial · NCT04907474
Evaluation of Pupil Dilation Speed With the MAP Dispenser
Eyenovia Inc.·phase4·completed·n = 61
Mydriasistropicamide-phenylephrine fixed combination ophthalmic solution
brief summary
1 mist or 2 mists of the study drug will be administered to both eyes according to a pre-specified randomization plan to determine the effect on pupil dilation
started
May 24, 2021
primary completion
Jun 3, 2021
completion
Jun 3, 2021
last updated
Jan 9, 2025
detailed description
After screening, eligible subjects will be scheduled for 2 treatment visits where either 1 mist or 2 mists of the study drug will be administered to both eyes according to a pre-specified randomization plan. Safety evaluations and efficacy measurements will be performed at specified time intervals thereafter.
Pupil dilation for each treatment will be compared at each time interval.
official title
A Study Evaluating Pupil Dilation Speed With the Micro-Array Print (MAP) Dispenser Comparing 2 Dosing Regimens of Tropicamide-Phenylephrine Fixed Combination Ophthalmic Solution
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol